HER3-targeted protein chimera forms endosomolytic capsomeres and self-assembles into stealth nucleocapsids for systemic tumor homing of RNA interference in vivo

Current Development of siRNA Bioconjugates: From Research to the Clinic

(2019) Ivan V. Chernikov et al.   Frontiers in Pharmacology

Recent advances in siRNA delivery for cancer therapy using smart nanocarriers

(2018) Penghui Zhang et al.   DRUG DISCOVERY TODAY

Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics

(2018) Jessica D. Sims et al.   JOURNAL OF CONTROLLED RELEASE

2018 White Paper on Recent Issues in Bioanalysis: ‘A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)’ (Part 1 – small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis)

(2018) Jan Welink et al.   Bioanalysis

Improving transparency and scientific rigor in academic publishing

(2018) Eric M. Prager et al.   Brain and Behavior

FOXC1: an emerging marker and therapeutic target for cancer

(2017) B Han et al.   ONCOGENE

Virus-inspired nucleic acid delivery system: Linking virus and viral mimicry

(2016) Rong Ni et al.   ADVANCED DRUG DELIVERY REVIEWS

Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?

(2016) Yuko Nakamura et al.   BIOCONJUGATE CHEMISTRY

Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy

(2016) Anish Babu et al.   IEEE TRANSACTIONS ON NANOBIOSCIENCE

Biomaterials in siRNA Delivery: A Comprehensive Review

(2016) William Ho et al.   Advanced Healthcare Materials

A corrole nanobiologic elicits tissue-activated MRI contrast enhancement and tumor-targeted toxicity

(2015) Jessica D. Sims et al.   JOURNAL OF CONTROLLED RELEASE

Cancer nanomedicine: addressing the dark side of the enhanced permeability and retention effect

(2015) Elizabeth Huynh et al.   Nanomedicine

ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth

(2015) J O Humtsoe et al.   ONCOGENE

HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models

(2015) Gaëlle Thomas et al.   Oncotarget

Activation of Multiple ERBB Family Receptors Mediates Glioblastoma Cancer Stem-like Cell Resistance to EGFR-Targeted Inhibition

(2015) Paul A. Clark et al.   NEOPLASIA

Role of erbB3 receptors in cancer therapeutic resistance

(2014) Y. Lee et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Production and applications of engineered viral capsids

(2014) Jeff Glasgow et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Adenovirus: The First Effective In Vivo Gene Delivery Vector

(2014) Ronald G. Crystal   HUMAN GENE THERAPY

ERBB3 is required for metastasis formation of melanoma cells

(2014) S Tiwary et al.   Oncogenesis

IGF-1R and ErbB3/HER3 contribute to enhanced proliferation and carcinogenesis in trastuzumab-resistant ovarian cancer model

(2013) Yanhan Jia et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy

(2013) G. D. L. Phillips et al.   CLINICAL CANCER RESEARCH

A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease

(2012) Punit Kaur et al.   BMC CANCER

Dual Blockade of HER2 in HER2-Overexpressing Tumor Cells Does Not Completely Eliminate HER3 Function

(2012) J. T. Garrett et al.   CLINICAL CANCER RESEARCH

HER3 Overexpression and Survival in Solid Tumors: A Meta-analysis

(2012) Alberto Ocana et al.   JNCI-Journal of the National Cancer Institute

Conserved Fiber-Penton Base Interaction Revealed by Nearly Atomic Resolution Cryo-Electron Microscopy of the Structure of Adenovirus Provides Insight into Receptor Interaction

(2012) C. Cao et al.   JOURNAL OF VIROLOGY

Chemotherapy targeting by DNA capture in viral protein particles

(2012) Hasmik Agadjanian et al.   Nanomedicine

Increasing Potential of HER3 Signaling in Colon Cancer Progression and Therapy

(2011) C. Gespach   CLINICAL CANCER RESEARCH

A Mechanistic Study of Tumor-Targeted Corrole Toxicity

(2011) Jae Youn Hwang et al.   MOLECULAR PHARMACEUTICS

Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors

(2011) A. Chakrabarty et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase

(2011) J. T. Garrett et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Graphical analysis of pH-dependent properties of proteins predicted using PROPKA

(2011) Michał Rostkowski et al.   BMC STRUCTURAL BIOLOGY

Delivery of siRNA Therapeutics: Barriers and Carriers

(2010) Jie Wang et al.   AAPS Journal

Model of the Trimeric Fiber and Its Interactions with the Pentameric Penton Base of Human Adenovirus by Cryo-electron Microscopy

(2010) Hongrong Liu et al.   JOURNAL OF MOLECULAR BIOLOGY

In Vivo Delivery of Antigens by Adenovirus Dodecahedron Induces Cellular and Humoral Immune Responses to Elicit Antitumor Immunity

(2010) Ana Villegas-Mendez et al.   MOLECULAR THERAPY

Trastuzumab-Induced HER Reprogramming in "Resistant" Breast Carcinoma Cells

(2009) M. Narayan et al.   CANCER RESEARCH

Adenovirus Dodecahedron, as a Drug Delivery Vector

(2009) Monika Zochowska et al.   PLoS One

Tumor detection and elimination by a targeted gallium corrole

(2009) H. Agadjanian et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Comparative Study on Overexpression of HER2/neu and HER3 in Gastric Cancer

(2009) Xiu Li Zhang et al.   WORLD JOURNAL OF SURGERY

Adenoviruses: update on structure and function

(2008) W. C. Russell   JOURNAL OF GENERAL VIROLOGY